IFI35 as a biomolecular marker of neuroinflammation and treatment response in multiple sclerosis
https://www.sciencedirect.com/science/a ... 0520309851
Highlights
• No biomarker is available for predicting treatment response and neuroinflammation in Multiple Sclerosis.
• IFI35 increases from the untreated to IFNbeta-1a treated MS patients, compared to HCs.
• IFI35 evidences predictive characteristics respect to lesion burden, WMF and formulation type of IFN.
• IFI35 discriminates the responder to IFN therapy from the non-responder patient.
• IFI35 biological pattern highlights a predictive profile drugs monitoring and innate immunity-dependent neuroinflammation.
biomarker for response to IFNbeta
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1395 Views
-
Last post by NHE
-
- 2 Replies
- 1791 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1012 Views
-
Last post by frodo
-
- 1 Replies
- 1001 Views
-
Last post by NHE
-
- 5 Replies
- 13532 Views
-
Last post by gibbledygook